Company: PTHS
Filing Date: 2025-09-29
Form Type: 424B3
Source: 0001753926-25-001561
Chunk: 63

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-09-29
Form: 424B3
Chunk 63
---
 (i) $1,000, subject to
adjustment, plus any all declared and unpaid dividends thereon as of such date of determination, plus any other amounts owed to
such holder pursuant to the Certificate of Designations, divided by (ii) $1 (adjusted to $10 as a result of the ten-for-one Reverse
Stock Split), subject to adjustments.

The shares of Series A Preferred Stock
to be issued and sold to the Selling Stockholders were not registered under the Securities Act, and were issued and sold in reliance
on the exemption from registration requirements thereof provided by Section 4(a)(2) of the Securities Act as a transaction by an
issuer not involving a public offering.

The Registration Rights Agreement

On the Merger Closing Date and in connection
with the Merger, the Company and the PIPE Investors entered into a registration rights agreement (the “Registration Rights
Agreement”) pursuant to which the PIPE Investors are entitled to certain resale registration rights with respect to shares
of the Company’s Common Stock issuable upon conversion of the Series A Preferred Stock issued to the PIPE Investors. Pursuant
to the Registration Rights Agreement, the Company is required to prepare and file a resale registration statement with the SEC
on or prior to the later of (i) 30 calendar days following the closing of the PIPE Financing and (ii) fifteen (15) calendar days
after the Company’s next periodic report required pursuant to Section 13 of the Exchange Act. The Company is obligated to
use reasonable best efforts to cause this registration statement to be declared effective by the SEC within 120 calendar days following
the closing of the PIPE Financing (or within 150 calendar days following the closing of the PIPE Financing if the SEC reviews the
registration statement).

<div align='center'>37

DESCRIPTION OF CAPITAL STOCK</div>

General

The following description of Pelthos’ securities is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to our articles of incorporation, and our bylaws, each of which are filed as an exhibit to Pelthos’ Current Report on Form 8-K for the year filed on July 2, 2025. Copies of these documents can be accessed through hyperlinks to those documents in the list of exhibits in our Current Report on Form 8-K filed on July 2, 2025.

Authorized Capital Stock

Pelthos’ authorized capital shares consist of (a) 200,000,000 shares of Common Stock